Innate Pharma SA
IPHA- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001598599
No open-market purchases or sales by Innate Pharma SA insiders were filed in the last 90 days; 10 institutions reported holding it in 13F filings for Q2 2026, worth $354.0K in total; no superinvestor holds it.
Other share classesIPHYF
Members of Congress who traded IPHA
No member of Congress has reported a trade in Innate Pharma SA since 2020.
Source: U.S. House Clerk and Senate Office of Public Records (eFD). Amounts are the ranges filers report.